Archive for 2012

  • aside

    First patient enrolled in Isofol Medical’s ISO-CC-002 trial

    Isofol Medical AB today announced that the the first patient in its randomized phase I/II trial, ISO-CC-002, has been enrolled.…

    by
  • aside

    Isofol Medical receives approval to conduct its second clinical phase I/II study of Modufolin® in patients with colon cancer

    Isofol Medical AB has received approval from the Swedish Medical Products Agency (Läkemedelsverket) to start a randomized phase I/II pharmacokinetic…

    by